EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study

Ludovic Meunier, Simon Eccleshall, Ronan Bakdi, Matthieu Godin, Géraud Souteyrand, Benoît Mottin, Yann Valy, Christian Benoit, Vincent Lordet, Virginie Laurençon, Antoine Milhem iD, Matthias Waliszewski und 1 weitere

Clinical Cardiology · 2025

DOI: 10.1002/clc.70189 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Ludovic Meunier und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Centre Hospitalier la Rochelle, la Rochelle, France. Hauptthemen laut MEDLINE: Coronary Artery Disease, Angioplasty, Balloon, Coronary, Drug-Eluting Stents, Coated Materials, Biocompatible. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Groupe Hospitalier de la Rochelle Ré Aunis [2018P02283] and B. Braun [l-FR-2019-0184/MEDAG-19-00166]..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Drug‐eluting stent (DES) angioplasty is the gold standard treatment for coronary lesions. Drug‐coated balloon (DCB) is an option for in‐stent restenosis, and has also shown promise for small‐calibre coronary artery disease. We evaluated the 3‐year effectiveness of a decision algorithm for percutaneous coronary intervention (PCI) that favoured a stent‐less strategy (SLS) in primary angioplasty.

Methods

All patients who underwent angioplasty during 1 year were included in a prospective observational study. Patients eligible for SLS first underwent scoring balloon followed by DCB angioplasty or DES in case of mandatory bailout. Patients not eligible for SLS were unstable patients who underwent conventional drug‐eluting stenting. The metal index, stent burden, was calculated by stent length divided by the total lesion length. A 36‐month follow‐up recorded target lesion revascularization (TLR).

Results

Patients eligible for SLS represented 85% ( n = 840) of patients who underwent PCI. TLR was required in 2.6% and 6% of patients in the DCB‐only and bailout‐DES groups, respectively. Median metal index was 0.25 (IQR: 0.5) in patients with TLR. There was a difference between TLR–free survival distributions in the DCB‐only and bailout‐DES groups ( p = 0.016).

Conclusions

The SLS based on a combination of scoring balloon and DCB was effective at 3 years with a low rate of TLR. This rate was higher in patients with stent burden. Trial Registration: This study was registered with clinicaltrials. gov (NCT03893396, first posted on March 28, 2019).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseAngioplasty, Balloon, CoronaryDrug-Eluting StentsCoated Materials, BiocompatibleCardiac CathetersPercutaneous Coronary InterventionCoronary RestenosisHumansMaleFemaleProspective StudiesFollow-Up StudiesAgedMiddle AgedTime FactorsTreatment OutcomeCoronary AngiographyProsthesis Design

Stichwörter der Autor:innen

DCB‐based strategyangioplastycoronary artery diseasedrug‐coated balloondrug‐eluting stentpatient outcome assessmentpercutaneous coronary intervention

Substanzen

Coated Materials, Biocompatible

Autor:innen und Institutionen

  • Cardiology Department, Centre Hospitalier la Rochelle, la Rochelle, France.
  • Norfolk and Norwich University Hospital, Norwich, UK.
  • Cardiology Department, Clinique St-Hilaire, Rouen, France.
  • Département de Cardiologie, CHU Clermont-Ferrand, ISIT, CaVITI, CNRS (UMR-6284), Université d'Auvergne, Clermont-Ferrand, France.
  • Clinical Trials Unit, Centre Hospitalier la Rochelle, la Rochelle, France.
  • Medical Scientific Affairs, B. Braun Melsungen AG, Berlin, Germany.

ORCID-Profile: Antoine Milhem, Caroline Allix-Béguec

Förderung

  • This study was supported by the Groupe Hospitalier de la Rochelle Ré Aunis [2018P02283] and B. Braun [l-FR-2019-0184/MEDAG-19-00166].

Zitieren

APA

Meunier, L., Eccleshall, S., Bakdi, R., Godin, M., Souteyrand, G., Mottin, B., Valy, Y., Benoit, C., Lordet, V., Laurençon, V., Milhem, A., Waliszewski, M., & Allix-Béguec, C. (2025). Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study. Clinical Cardiology. https://doi.org/10.1002/clc.70189

Vancouver

Meunier L, Eccleshall S, Bakdi R, Godin M, Souteyrand G, Mottin B, et al. Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study. Clinical Cardiology. 2025. doi:10.1002/clc.70189

BibTeX
@article{Meunier2025,
  author = {Meunier, Ludovic and Eccleshall, Simon and Bakdi, Ronan and Godin, Matthieu and Souteyrand, Géraud and Mottin, Benoît and Valy, Yann and Benoit, Christian and Lordet, Vincent and Laurençon, Virginie and Milhem, Antoine and Waliszewski, Matthias and Allix-Béguec, Caroline},
  title = {Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study},
  journal = {Clinical Cardiology},
  year = {2025},
  doi = {10.1002/clc.70189}
}
Kostenlos starten →